Mark is president of Myriad Neuroscience.
Mark leads the Myriad Neuroscience team in its quest to improve patients’ lives through advanced genetic science.
Named president in 2018, Mark was previously senior vice president, chief sales and business development officer for the company. Prior to joining Myriad, Mark held leadership roles for nearly two decades in the healthcare diagnostics and device industries with Forest Laboratories and Cyberonics.
Mark earned a B.S. in life sciences with a minor in physiology from The Pennsylvania State University.